Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-5,900
Closed -$491K 1242
2021
Q3
$491K Sell
5,900
-38,400
-87% -$3.29M ﹤0.01% 1062
2021
Q2
$3.9M Sell
44,300
-17,400
-28% -$1.59M 0.01% 767
2021
Q1
$5.49M Buy
+61,700
New +$5.04M 0.02% 686
2020
Q4
Sell
-146,600
Closed -$10M 1314
2020
Q3
$10M Sell
146,600
-2,200
-1% -$162K 0.04% 453
2020
Q2
$10.5M Buy
148,800
+50,200
+51% +$3.38M 0.04% 415
2020
Q1
$5.74M Buy
98,600
+67,000
+212% +$4.55M 0.03% 490
2019
Q4
$2.35M Sell
31,600
-116,200
-79% -$8.73M 0.01% 778
2019
Q3
$11.4M Sell
147,800
-47,400
-24% -$3.6M 0.05% 431
2019
Q2
$14.2M Buy
195,200
+129,100
+195% +$9.37M 0.06% 378
2019
Q1
$4.69M Buy
+66,100
New +$4.63M 0.02% 662

Other funds holding MMS

Axa's MMS Position: Q4 2021 in Review

Axa sold out of Maximus (MMS) in Q4 2021, closing a stake of 5,900 shares — an estimated $491K sold.

Axa first reported a position in MMS in Q1 2019 and held it in 10 quarters. The position peaked at $14.2M in Q2 2019. 348 funds tracked by Wall St. Rank hold MMS as of Q4 2021.

  • Axa reported no remaining Maximus position as of Q4 2021 after selling out during the quarter.
  • Axa sold 5,900 Maximus shares in Q4 2021, an estimated $491K.
  • Axa first reported a position in Maximus in Q1 2019 and held it in 10 quarters.
  • Axa's Maximus position peaked at $14.2M in Q2 2019.
  • 348 funds tracked by Wall St. Rank held Maximus as of Q4 2021.

Based on Axa's 13F filing for Q4 2021, filed 14 Feb 2022.